Property Management Software Market Poised for Growth, Expected to Hit USD 54.16 Billion by 2032 -Coherent Market Insights

Property Management Software Market Poised for Growth, Expected to Hit USD 54.16 Billion by 2032 -Coherent Market Insights GlobeNewswire July 01, 2025 Burlingame, CA, July 01, 2025 (GLOBE NEWSWIRE) — The global property management software market is estimated to be valued at USD 27.95 Billion in 2025 and is expected to reach USD 54.16 Billion […]

NEW FLAVORS ARRIVE THIS SEASON AT TEXAS DE BRAZIL

Savor the Return of Brazilian Classics:Moqueca de Camarão & Grilled Shrimp Texas de Brazilis proud to unveil its third-quarter menu additions, inviting guests to indulge in the vibrant, bold tastes of Brazil with two returning seasonal favorites: Moqueca de Camarão and Grilled Shrimp. These flavorful features are now available for a limited time at all

MariMed Statement Regarding the Commencement of Adult-Use Cannabis Sales in Delaware on August 1st

(Other OTC:MRMD),(OTC US:MRMD),(CNSX:MRMD.CN),(CNSX:MRMD), NORWOOD, Mass., July 01, 2025 (GLOBE NEWSWIRE) — Following today's announcement that Delaware will commence adult-use sales of cannabis, MariMed CEO Jon Levine released the following statement: “We are excited to participate in the expansion of Delaware's cannabis program to include adult-use sales. Our Delaware business unit, First State Compassion (“FSC”), was

MariMed Statement Regarding the Commencement of Adult-Use Cannabis Sales in Delaware on August 1st

MariMed Statement Regarding the Commencement of Adult-Use Cannabis Sales in Delaware on August 1st GlobeNewswire July 01, 2025 NORWOOD, Mass., July 01, 2025 (GLOBE NEWSWIRE) — Following today's announcement that Delaware will commence adult-use sales of cannabis, MariMed CEO Jon Levine released the following statement: “We are excited to participate in the expansion of Delaware's

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against CTO Realty Growth, Inc. (CTO) And Encourages Investors to Reach Out

NEW YORK CITY, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CTO Realty Growth, Inc. ("CTO" or "the Company") (NYSE:CTO). Investors who purchased CTO securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site:

Bronstein, Gewirtz & Grossman, LLC Is Investigating Apple Inc. (AAPL) And Encourages Investors to Connect

NEW YORK, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Apple Inc. ("Apple" or "the Company") (NASDAQ:AAPL). Investors who purchased Apple securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/AAPL. Investigation Details

Bronstein, Gewirtz & Grossman, LLC Encourages Innodata Inc. (INOD) Stockholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Innodata Inc. ("Innodata" or "the Company") (NASDAQ:INOD). Investors who purchased Innodata securities prior to May 9, 2019, and continue to hold to the present, are encouraged to obtain additional

Atkore Inc. (ATKR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

NEW YORK, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Atkore Inc. ("Atkore" or "the Company") (NYSE:ATKR). Investors who purchased Atkore securities prior to August 2, 2022, and continue to hold to the present, are encouraged to obtain additional information

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lifecore Biomedical, Inc. ("Lifecore" or "the Company") (NASDAQ: LFCR). Investors who purchased Lifecore securities prior to October 7, 2020, and continue to hold to the present, are encouraged to

Scroll to Top